KR102510213B1 - The adhesive transparent wound covering material composition containing fumaria officinalis, pomegranate shell extract and comfrey leaf extract - Google Patents
The adhesive transparent wound covering material composition containing fumaria officinalis, pomegranate shell extract and comfrey leaf extract Download PDFInfo
- Publication number
- KR102510213B1 KR102510213B1 KR1020220125528A KR20220125528A KR102510213B1 KR 102510213 B1 KR102510213 B1 KR 102510213B1 KR 1020220125528 A KR1020220125528 A KR 1020220125528A KR 20220125528 A KR20220125528 A KR 20220125528A KR 102510213 B1 KR102510213 B1 KR 102510213B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- weight
- parts
- skin
- adhesive transparent
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 71
- 239000000853 adhesive Substances 0.000 title claims abstract description 40
- 230000001070 adhesive effect Effects 0.000 title claims abstract description 40
- 229940039585 comfrey leaf extract Drugs 0.000 title claims abstract description 38
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 235000014360 Punica granatum Nutrition 0.000 title claims abstract description 8
- 244000294611 Punica granatum Species 0.000 title claims 2
- 239000000463 material Substances 0.000 title abstract description 18
- 244000044980 Fumaria officinalis Species 0.000 title abstract description 5
- 235000006961 Fumaria officinalis Nutrition 0.000 title abstract description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 46
- 239000001575 punica granatum l. bark extract Substances 0.000 claims abstract description 36
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- BQMNFPBUAQPINY-UHFFFAOYSA-N azane;2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid Chemical compound [NH4+].[O-]S(=O)(=O)CC(C)(C)NC(=O)C=C BQMNFPBUAQPINY-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000008213 purified water Substances 0.000 claims abstract description 14
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims abstract description 12
- 229960000458 allantoin Drugs 0.000 claims abstract description 12
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims abstract description 11
- 229940101267 panthenol Drugs 0.000 claims abstract description 11
- 235000020957 pantothenol Nutrition 0.000 claims abstract description 11
- 239000011619 pantothenol Substances 0.000 claims abstract description 11
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 claims abstract description 10
- 229920002498 Beta-glucan Polymers 0.000 claims abstract description 10
- 229940015975 1,2-hexanediol Drugs 0.000 claims abstract description 9
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 claims abstract description 9
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 claims abstract description 9
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000005865 Symphytum officinale Nutrition 0.000 claims abstract description 7
- 241001442052 Symphytum Species 0.000 claims abstract description 6
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 claims abstract 2
- 241000218176 Corydalis Species 0.000 claims description 34
- 239000008199 coating composition Substances 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 10
- 241000212948 Cnidium Species 0.000 claims description 9
- 241000721098 Epilobium Species 0.000 claims description 8
- 229940069445 licorice extract Drugs 0.000 claims description 7
- -1 1,3-butylene glycol ethylhexylglycerin Chemical compound 0.000 claims description 4
- 229940111793 eggplant extract Drugs 0.000 claims description 4
- 241000195493 Cryptophyta Species 0.000 claims description 3
- 229940029991 coriander extract Drugs 0.000 claims description 3
- 241000283690 Bos taurus Species 0.000 claims description 2
- 244000170916 Paeonia officinalis Species 0.000 claims description 2
- 210000004761 scalp Anatomy 0.000 abstract description 32
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 abstract description 24
- 230000008591 skin barrier function Effects 0.000 abstract description 16
- 229940058015 1,3-butylene glycol Drugs 0.000 abstract description 12
- 235000019437 butane-1,3-diol Nutrition 0.000 abstract description 12
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 abstract description 9
- 206010013786 Dry skin Diseases 0.000 abstract description 9
- 230000037336 dry skin Effects 0.000 abstract description 9
- 229940100524 ethylhexylglycerin Drugs 0.000 abstract description 9
- 241000219991 Lythraceae Species 0.000 abstract description 6
- 230000037390 scarring Effects 0.000 abstract description 5
- 230000005722 itchiness Effects 0.000 abstract description 2
- 206010052428 Wound Diseases 0.000 description 48
- 208000027418 Wounds and injury Diseases 0.000 description 48
- 210000003491 skin Anatomy 0.000 description 47
- 230000000052 comparative effect Effects 0.000 description 27
- 230000006872 improvement Effects 0.000 description 25
- 238000000605 extraction Methods 0.000 description 15
- 230000000694 effects Effects 0.000 description 12
- 206010015150 Erythema Diseases 0.000 description 10
- 231100000321 erythema Toxicity 0.000 description 10
- 238000001914 filtration Methods 0.000 description 10
- 230000003020 moisturizing effect Effects 0.000 description 10
- 230000000704 physical effect Effects 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 9
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 8
- 241000736199 Paeonia Species 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 238000004108 freeze drying Methods 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 6
- 230000007803 itching Effects 0.000 description 6
- 230000002335 preservative effect Effects 0.000 description 6
- 206010037888 Rash pustular Diseases 0.000 description 5
- 235000020221 chamomile extract Nutrition 0.000 description 5
- 229940119217 chamomile extract Drugs 0.000 description 5
- 230000003750 conditioning effect Effects 0.000 description 5
- 230000003325 follicular Effects 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 208000029561 pustule Diseases 0.000 description 5
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 4
- 230000003266 anti-allergic effect Effects 0.000 description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 239000000843 powder Substances 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- 240000003291 Armoracia rusticana Species 0.000 description 3
- 235000011330 Armoracia rusticana Nutrition 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 229940010454 licorice Drugs 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 240000004670 Glycyrrhiza echinata Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- NHTMVDHEPJAVLT-UHFFFAOYSA-N Isooctane Chemical compound CC(C)CC(C)(C)C NHTMVDHEPJAVLT-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 2
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- DIOQZVSQGTUSAI-UHFFFAOYSA-N decane Chemical compound CCCCCCCCCC DIOQZVSQGTUSAI-UHFFFAOYSA-N 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- JVSWJIKNEAIKJW-UHFFFAOYSA-N dimethyl-hexane Natural products CCCCCC(C)C JVSWJIKNEAIKJW-UHFFFAOYSA-N 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- BKIMMITUMNQMOS-UHFFFAOYSA-N nonane Chemical compound CCCCCCCCC BKIMMITUMNQMOS-UHFFFAOYSA-N 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241001133760 Acoelorraphe Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241000555682 Forsythia x intermedia Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 241000606768 Haemophilus influenzae Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 240000001090 Papaver somniferum Species 0.000 description 1
- 208000004210 Pressure Ulcer Diseases 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 208000002847 Surgical Wound Diseases 0.000 description 1
- 240000002299 Symphytum officinale Species 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 239000002870 angiogenesis inducing agent Substances 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 238000004649 discoloration prevention Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 229910052732 germanium Inorganic materials 0.000 description 1
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 150000002304 glucoses Chemical class 0.000 description 1
- JPCBEVHCIJLZFV-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO.CCCCC(O)CO JPCBEVHCIJLZFV-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 239000000416 hydrocolloid Substances 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 description 1
- DXDRHHKMWQZJHT-FPYGCLRLSA-N isoliquiritigenin Chemical compound C1=CC(O)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O DXDRHHKMWQZJHT-FPYGCLRLSA-N 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 235000008718 isoliquiritigenin Nutrition 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 231100000065 noncytotoxic Toxicity 0.000 description 1
- 230000002020 noncytotoxic effect Effects 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 229940090181 propyl acetate Drugs 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/58—Adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/30—Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Abstract
Description
본 발명은 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물에 관한 것으로서, 더 상세하게는 건조한 피부 및 두피 등 피부 장벽이 손상된 부위의 보호를 위해서 피부 장벽이 파괴된 피부 및 두피에 물리적인 막을 형성하고, 피부 환경에 수분을 유지시킬 수 있는 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물에 관한 것이다.The present invention relates to an adhesive transparent wound covering composition containing a coriander extract, a pomegranate peel extract, and a comfrey leaf extract, and more particularly, to protect areas where the skin barrier is damaged, such as dry skin and scalp, where the skin barrier is broken. It relates to an adhesive transparent wound covering composition containing corydalis extract, pomegranate peel extract, and comfrey leaf extract capable of forming a physical film on the skin and scalp and retaining moisture in the skin environment.
창상은 외부의 압력에 의하여 조직의 연속성이 파괴되거나, 일부 영역에 결손이 생기는 상태이다. 단순 외상 등의 경도의 창상은 자기 수복 기능에 의한 재생이 가능하지만, 중증 화상이나 복합 창상, 욕창, 외과적 수술에 의한 창상 등의 난치성 창상은 완전한 수복이 어렵다. 난치성 창상이나 광범위한 창상은 조직 본연의 기능 수행에 결함을 남길 수 있으므로, 창상부위를 신속하게 치료하고 이차적인 각종 부작용을 최소화하기 위한 치료가 필수적이다.A wound is a state in which the continuity of tissue is destroyed by external pressure or a defect occurs in some area. Mild wounds such as simple trauma can be regenerated by self-healing function, but it is difficult to completely repair intractable wounds such as severe burns, complex wounds, bedsores, and surgical wounds. Intractable wounds or extensive wounds may leave defects in the functioning of the tissue, so treatment to quickly treat the wound and minimize various secondary side effects is essential.
창상은 건조된 상태보다 습윤 상태를 유지하는 경우 치유속도가 2배 정도 빠른 것으로 알려져 있다. 따라서, 종래에는 습윤 상태를 유지하기 위하여 생리학적 용액이나 소독제를 함유한 용액으로 적신 거즈로 드레싱하는 방법이 사용되었다. 그러나, 이는 드레싱의 교체 주기가 잦아야 하므로 관리가 번거롭고, 창상부위 뿐만 아니라 주변부 역시 생리학적 용액이나 소독제에 의해 젖은 상태가 유지되어 피부의 짓무름을 유발하는 문제가 있었다. It is known that the healing rate of wounds is about twice as fast when they are kept wet than when they are dry. Therefore, conventionally, a method of dressing with gauze soaked in a physiological solution or a solution containing a disinfectant has been used to maintain a wet state. However, this is cumbersome to manage because the dressing replacement cycle must be frequent, and not only the wound area but also the surrounding area is kept wet by a physiological solution or disinfectant, causing soreness of the skin.
최근에는 하이드로겔이나 하이드로콜로이드와 같은 창상 피복재를 사용하여 환부를 보호하는 것과 함께, 체내로부터의 수분 누출을 방지하고 삼출액을 흡수하여 습윤환경을 유지하도록 하는 방법이 많이 사용되고 있다. 하지만, 신체의 굴곡진 부위 등에 밀착이 잘되지 않고 쉽게 떨어지거나, 사용부위별로 크기에 맞는 창상 피복재를 사용하거나 잘라서 사용해야 하는 단점이 있다.Recently, a method of protecting the affected area using a wound covering material such as a hydrogel or a hydrocolloid, preventing water leakage from the body and absorbing exudate to maintain a moist environment has been widely used. However, there is a disadvantage in that it does not adhere well to the curved parts of the body and easily falls off, or a wound covering material suitable for the size of each used part must be used or cut.
또한, 피부의 가벼운 찰과상 등에 사용하기 위한 액상 창상 피복재들이 개발되어 사용되고 있다. 여기에는 니트로셀룰로오스, 폴리우레탄, 폴리비닐피롤리돈 또는 아크릴레이트 등이 주재료로 사용된다. 이러한 액상 창상 피복재를 제조하기 위한 용매로는 물, 에틸아세테이트 및 이소옥탄 등이 사용되는데, 상기 액상 창상 피복재들은 상처에 의해 발생할 수 있는 흉터의 완화 기능은 지니고 있지 않으며, 상처의 가려움이나 염증 완화 기능이 부족한 것으로 알려져 있다.In addition, liquid wound covering materials for use on light abrasions and the like of the skin have been developed and used. Here, nitrocellulose, polyurethane, polyvinylpyrrolidone or acrylate are used as main materials. Water, ethyl acetate, isooctane, etc. are used as solvents for preparing such liquid wound coating materials. known to be lacking.
따라서, 피부 및 두피 등 피부 장벽이 손상된 부위의 보호를 위해서 피부 장벽이 파괴된 피부 및 두피에 물리적인 막을 형성하고, 피부 환경에 수분을 유지시킬 수 있는 세포독성이 없고 자극이 없는 천연추출물을 함유한 점착성 투명 창상 피복재 조성물의 개발이 필요한 실정이다. Therefore, in order to protect the skin and scalp where the skin barrier is damaged, it contains natural extracts that are non-cytotoxic and non-irritating to form a physical film on the skin and scalp where the skin barrier is destroyed and to maintain moisture in the skin environment. There is a need to develop an adhesive transparent wound covering composition.
본 발명은 상기 종래기술이 갖는 문제점을 해결하기 위해서 안출된 것으로서, 본 발명에서 해결하고자 하는 과제는 피부 장벽이 파괴된 피부 및 두피에 물리적인 막을 형성하고, 피부 환경에 수분을 유지시킬 수 있는 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유한 점착성 투명 창상 피복재 조성물을 제공함에 그 목적이 있다. The present invention has been made to solve the problems of the prior art, and the problem to be solved in the present invention is to form a physical film on the skin and scalp where the skin barrier is destroyed, and to maintain moisture in the skin environment. An object of the present invention is to provide an adhesive transparent wound covering composition containing comb corydalis extract, pomegranate peel extract and comfrey leaf extract.
또 다른 목적으로는 신체의 굴곡진 부위나 복잡한 3차원 구조의 피부에 적용이 용이하고 탄력성 및 유연성을 갖는 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물을 제공함에 그 목적이 있다. Another object is to provide an adhesive transparent wound covering composition containing Corydalis extract, pomegranate peel extract and comfrey leaf extract that is easy to apply to curved parts of the body or skin with a complex three-dimensional structure and has elasticity and flexibility. It has a purpose.
상기와 같은 목적을 달성하기 위한 본 발명에 따른 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물은 정제수, 에탄올(Ethanol), 베타글루칸(β-glucan), 둥글빗살현호색추출물, 석류과피추출물, 컴프리잎추출물, 판테놀(panthenol), 1,2-헥산다이올(1,2-Hexanediol), 1,3-부틸렌글리콜(1,3-Butylene glycol), 에틸헥실클리세린(Ethylhexylglycerin), 알란토인(allantoin), 디소듐이디티에이(disodium EDTA) 및 암모늄아크릴로일디메칠타우레이트(Ammonium Acryloyldimethyltaurate)를 포함하는 것을 특징으로 한다. In order to achieve the above object, the adhesive transparent wound covering composition containing corydalis extract, pomegranate peel extract and comfrey leaf extract according to the present invention is purified water, ethanol, β-glucan, round comb Corydalis extract, pomegranate peel extract, comfrey leaf extract, panthenol, 1,2-hexanediol, 1,3-butylene glycol, ethylhexyl glycol It is characterized by including serine (Ethylhexylglycerin), allantoin, disodium EDTA and ammonium acryloyldimethyltaurate (Ammonium Acryloyldimethyltaurate).
또, 상기 정제수 100중량부에 대하여, 에탄올(ethanol) 10~20중량부, 베타글루칸(β-glucan) 7~15중량부, 둥글빗살현호색추출물 2~3중량부, 석류과피추출물 3~5중량부, 컴프리잎추출물 1~2중량부, 판테놀(panthenol) 7~15중량부, 1,2-헥산다이올(1,2-Hexanediol) 2~5중량부, 1,3-부틸렌글리콜(1,3-Butylene glycol) 1~3중량부, 에틸헥실클리세린(Ethylhexylglycerin) 0.05~0.1중량부, 알란토인(allantoin) 0.03~0.1중량부, 디소듐이디티에이(disodium EDTA) 0.01~0.05중량부 및 암모늄아크릴로일디메칠타우레이트(Ammonium Acryloyldimethyltaurate) 1~3중량부를 포함하는 것을 특징으로 한다. In addition, with respect to 100 parts by weight of the purified water, 10 to 20 parts by weight of ethanol, 7 to 15 parts by weight of beta-glucan, 2 to 3 parts by weight of Corydalis extract, 3 to 5 parts by weight of pomegranate peel extract Comfrey leaf extract 1-2 parts by weight, panthenol 7-15 parts by weight, 1,2-hexanediol 2-5 parts by weight, 1,3-butylene glycol (1 ,3-Butylene glycol) 1-3 parts by weight, Ethylhexylglycerin 0.05-0.1 parts by weight, Allantoin 0.03-0.1 parts by weight, Disodium EDTA 0.01-0.05 parts by weight, and Characterized in that it comprises 1 to 3 parts by weight of ammonium acryloyldimethyltaurate (Ammonium Acryloyldimethyltaurate).
또, 상기 정제수 100중량부에 대하여, 갈근추출물, 감초추출물, 천궁추출물, 지실추출물, 작약추출물 및 에필로비움플레이스케리추출물을 동량으로 혼합한 혼합물 3~7중량부를 더 포함하는 것을 특징으로 한다. In addition, with respect to 100 parts by weight of the purified water, it is characterized in that it further comprises 3 to 7 parts by weight of a mixture obtained by mixing equal amounts of horseradish root extract, licorice extract, cnidium extract, eggplant extract, peony extract and epilobium place skerry extract.
또, 상기 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물은 점도 300~7,000cPs, pH 4~7로 형성되는 것을 특징으로 한다. In addition, the adhesive transparent wound coating composition containing the coriander extract, pomegranate peel extract and comfrey leaf extract is characterized in that it is formed at a viscosity of 300 to 7,000 cPs and a pH of 4 to 7.
본 발명에 따르면, 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물 등의 천연추출물을 포함한 점착성 투명 창상 피복재 조성물을 통해 건조한 피부 및 두피 등 피부 장벽이 손상된 부위를 보호하고, 피부 장벽이 파괴된 피부 및 두피에 물리적인 막을 형성하며, 피부 환경에 수분을 유지시켜 건조된 피부로 인한 가려움 내지 흉터 발생을 완화해 줄 수 있는 효과가 있다.According to the present invention, through an adhesive transparent wound covering composition containing natural extracts such as chamomile extract, pomegranate peel extract, and comfrey leaf extract, it protects areas where the skin barrier is damaged, such as dry skin and scalp, and the skin barrier is destroyed. And it forms a physical film on the scalp, and has an effect of relieving itching or scarring due to dry skin by maintaining moisture in the skin environment.
도 1 내지 도 5는 본 발명에 따른 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물을 이용하여 제조된 점착성 투명 창상 피복재(실시예 1)의 두피 도포 전 후의 사진이다.
도 6 내지 도 10은 본 발명에 따른 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물을 이용하여 제조된 점착성 투명 창상 피복재(실시예 2)의 두피 도포 전 후의 사진이다. 1 to 5 are photos before and after scalp application of an adhesive transparent wound coating material (Example 1) prepared using an adhesive transparent wound coating composition containing corydalis corydalis extract, pomegranate peel extract and comfrey leaf extract according to the present invention am.
6 to 10 are photos before and after scalp application of the adhesive transparent wound coating material (Example 2) prepared using the adhesive transparent wound coating composition containing corydalis corydalis extract, pomegranate peel extract and comfrey leaf extract according to the present invention am.
이하, 본 발명을 상세히 설명하고자 한다. Hereinafter, the present invention will be described in detail.
본 발명은 피부, 두피 등 피부 장벽이 손상된 부위의 보호를 위해서, 피부 장벽이 파괴된 피부 및 두피에 물리적인 막을 형성하고, 피부 환경에 수분을 유지시킬 수 있는 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물을 제공하고자 하는 것으로서, 이러한 본 발명은 정제수, 에탄올(Ethanol), 베타글루칸(β-glucan), 둥글빗살현호색추출물, 석류과피추출물, 컴프리잎추출물, 판테놀(panthenol), 1,2-헥산다이올(1,2-Hexanediol), 1,3-부틸렌글리콜(1,3-Butylene glycol), 에틸헥실클리세린(Ethylhexylglycerin), 알란토인(allantoin), 디소듐이디티에이(disodium EDTA) 및 암모늄아크릴로일디메칠타우레이트(Ammonium Acryloyldimethyltaurate)를 포함하여 이루어진다. In order to protect areas where the skin barrier is damaged, such as the skin and scalp, the present invention forms a physical film on the skin and scalp where the skin barrier is destroyed, and contains Corydalis extract, pomegranate rind extract, and It is intended to provide an adhesive transparent wound covering composition containing comfrey leaf extract, and the present invention is to provide purified water, ethanol, beta-glucan, corydalis chamomile extract, pomegranate peel extract, comfrey leaf extract, panthenol (panthenol), 1,2-hexanediol, 1,3-butylene glycol, ethylhexylglycerin, allantoin, disodium It is composed of disodium EDTA and ammonium acryloyldimethyltaurate.
더 상세하게는, 정제수 100중량부에 대하여, 에탄올(ethanol) 10~20중량부, 베타글루칸(β-glucan) 7~15중량부, 둥글빗살현호색추출물 2~3중량부, 석류과피추출물 3~5중량부, 컴프리잎추출물 1~2중량부, 판테놀(panthenol) 7~15중량부, 1,2-헥산다이올(1,2-Hexanediol) 2~5중량부, 1,3-부틸렌글리콜(1,3-Butylene glycol) 1~3중량부, 에틸헥실클리세린(Ethylhexylglycerin) 0.05~0.1중량부, 알란토인(allantoin) 0.03~0.1중량부, 디소듐이디티에이(disodium EDTA) 0.01~0.05중량부 및 암모늄아크릴로일디메칠타우레이트(Ammonium Acryloyldimethyltaurate) 1~3중량부를 포함한다. More specifically, based on 100 parts by weight of purified water, 10 to 20 parts by weight of ethanol, 7 to 15 parts by weight of beta-glucan, 2 to 3 parts by weight of Corydalis extract, 3 to 3 parts by weight of pomegranate peel extract 5 parts by weight, comfrey leaf extract 1-2 parts by weight, panthenol 7-15 parts by weight, 1,2-hexanediol 2-5 parts by weight, 1,3-butylene glycol (1,3-Butylene glycol) 1-3 parts by weight, Ethylhexylglycerin 0.05-0.1 parts by weight, Allantoin 0.03-0.1 parts by weight, Disodium EDTA 0.01-0.05 parts by weight part and ammonium acryloyldimethyltaurate (Ammonium Acryloyldimethyltaurate) 1 to 3 parts by weight.
본 발명에 따른 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물은 정제수, 에탄올(Ethanol), 베타글루칸(β-glucan), 둥글빗살현호색추출물, 석류과피추출물, 컴프리잎추출물, 판테놀(panthenol), 1,2-헥산다이올(1,2-Hexanediol), 1,3-부틸렌글리콜(1,3-Butylene glycol), 에틸헥실클리세린(Ethylhexylglycerin), 알란토인(allantoin), 디소듐이디티에이(disodium EDTA) 및 암모늄아크릴로일디메칠타우레이트(Ammonium Acryloyldimethyltaurate)의 각각 고유의 유효한 성분들이 서로 조화를 이루고 상호보완작용을 하여 각각의 성분을 단독으로 사용하거나 일부 성분만을 배합하여서는 얻어질 수 없다.The adhesive transparent wound covering composition containing corydalis extract, pomegranate peel extract and comfrey leaf extract according to the present invention is purified water, ethanol, beta-glucan, corydalis extract, pomegranate peel extract, comfrey Leaf extract, panthenol, 1,2-hexanediol, 1,3-butylene glycol, ethylhexylglycerin, allantoin ), disodium EDTA, and Ammonium Acryloyldimethyltaurate, each unique effective ingredient harmonizes with each other and complements each other, so that each ingredient can be used alone or only some of the ingredients can be used. It cannot be obtained by mixing.
먼저, 액상형태의 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물을 형성하기 위하여서는 타 조성물들을 용해시켜 균일한 용액을 얻을 수 있도록 용매를 사용하는 것으로서, 상기 용매로는 물, 에탄올, 메탄올, 프로판올, 이소프로판올, 부탄올, 펜탄올, 메틸아세테이트, 에틸아세테이트, 프로필아세테이트, 부틸아세테이트, 이소펜틸아세테이트, 디메틸케톤, 메틸에틸케톤, 디에틸케톤, 디이소프로필 아디페이트, 이소프로필 팔미테이트, 펜탄, 헥산, 헵탄, 옥탄, 이소옥탄, 노난, 데칸 및 이소도데칸 중에서 선택된 어느 하나 또는 2 이상의 혼합 용매를 사용할 수 있다. First, in order to form an adhesive transparent wound coating composition containing corydalis extract, pomegranate peel extract and comfrey leaf extract in liquid form, a solvent is used to obtain a uniform solution by dissolving other compositions, the solvent As water, ethanol, methanol, propanol, isopropanol, butanol, pentanol, methyl acetate, ethyl acetate, propyl acetate, butyl acetate, isopentyl acetate, dimethyl ketone, methyl ethyl ketone, diethyl ketone, diisopropyl adipate, Any one selected from isopropyl palmitate, pentane, hexane, heptane, octane, isooctane, nonane, decane, and isododecane, or a mixed solvent of two or more may be used.
본 발명에서는 정제수와 에탄올을 혼합하여 사용한다. In the present invention, a mixture of purified water and ethanol is used.
만약, 정제수와 에탄올을 상기의 범위 미만으로 사용할 경우에는 타 조성물들을 충분히 용해시키기 어려워 균일한 용액을 얻기 어려우며, 상기의 범위를 초과하여 사용할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If purified water and ethanol are used in less than the above range, it is difficult to sufficiently dissolve other compositions and it is difficult to obtain a uniform solution.
베타글루칸(β-glucan)은 버섯, 귀리, 보리, 미역 등 효모의 세포벽에서 추출한 여러 개의 포도당으로 이루어진 고분자 성분으로서, 항염작용 및 면역세포의 면역기능 활성화작용을 하고, 감염된 균이나 죽은 세포를 제거하여 혈관형성인자의 분비를 유도해 정상적인 새로운 피부를 재생시키는 피부치유효과 및 노화방지효과가 뛰어나며, 콜라겐 합성에 도움을 주어 피부에 보호막을 형성하기 때문에 외부 자극에 의한 피부 오염에서 피부를 보호해 주는 역할을 한다. Beta-glucan is a high molecular component composed of several glucoses extracted from the cell walls of yeasts such as mushrooms, oats, barley, and seaweed. It induces the secretion of angiogenic factors and has excellent skin healing and anti-aging effects that regenerate normal new skin. play a role
만약, 베타글루칸을 상기의 범위 미만으로 포함할 경우에는 그 효과가 미미하며, 상기의 범위를 초과하여 포함할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If beta-glucan is included in an amount less than the above range, the effect is insignificant, and if it is included in an amount exceeding the above range, physical properties may deteriorate due to a content greater than necessary.
먼저, 본 발명에서 사용되는 추출물들을 제조하는 방법은 특별히 제한하지 않으며, 용매추출, 열수추출, 환류냉각추출, 초음파추출 및 여과법 등 당업계에서 알려진 통상적인 방법으로 수행될 수 있다. First, the method for preparing the extracts used in the present invention is not particularly limited, and may be performed by conventional methods known in the art, such as solvent extraction, hot water extraction, reflux cooling extraction, ultrasonic extraction and filtration.
본 발명에서는 유기용매를 이용한 용매추출을 통해 추출하고, 이를 위해 사용되는 유기용매는 에탄올, 메탄올, 부탄올, 에테르, 에틸아세테이트, 클로로포름 또는 이들 유기용매를 혼합하여 선택될 수 있으며, 바람직하게는 70% 에탄올을 사용하는 것이다. In the present invention, extraction is performed through solvent extraction using an organic solvent, and the organic solvent used for this purpose may be selected from ethanol, methanol, butanol, ether, ethyl acetate, chloroform or a mixture of these organic solvents, preferably 70% to use ethanol.
먼저, 둥글빗살현호색추출물은 둥글빗살현호색을 세척하고 건조하여 분쇄하고, 용매를 첨가하여 추출한 후, 여과 및 감압 농축하고 동결건조하여 제조한다. First, Corydalis Corydalis extract is prepared by washing, drying, and pulverizing Corydalis Corydalis, extracting by adding a solvent, filtering, concentrating under reduced pressure, and freeze-drying.
더 상세하게는, 세척하고 수분함량이 5중량% 이하가 되도록 건조하여 100~200mesh의 크기로 분쇄한 둥글빗살현호색 100중량부에 70% 에탄올 500~1,000중량부를 혼합하고 60~80℃에서 2~4시간 동안 2~5회 반복추출하여 여과한 후, 회전증발농축기로 농축하고 동결건조하여 제조한다. More specifically, 500 to 1,000 parts by weight of 70% ethanol was mixed with 100 parts by weight of 100 parts by weight of 100 parts by weight of 100 parts by weight of corystal, which was washed, dried to a moisture content of 5% by weight or less, and pulverized to a size of 100 to 200 mesh. It is prepared by repeatedly extracting 2 to 5 times for 4 hours, filtering, concentrating with a rotary evaporator, and freeze-drying.
여기서, 상기 추출온도 및 추출시간을 벗어나게 되면 추출효율이 떨어지거나 성분의 변화가 생길 수 있다. Here, if the extraction temperature and extraction time are out of range, the extraction efficiency may decrease or the components may change.
바람직하게는, 세척하고 수분함량이 5중량% 이하가 되도록 건조하여 150mesh의 크기로 분쇄한 둥글빗살현호색 100중량부에 70% 에탄올 700중량부를 혼합하고 70℃에서 3시간 동안 3회 반복추출하여 여과한 후, 회전증발농축기로 농축하고 72시간 동결건조하여 300mesh 크기의 분말화한다.Preferably, 700 parts by weight of 70% ethanol is mixed with 100 parts by weight of 100 parts by weight of Corydalis, which is washed, dried to a water content of 5% by weight or less, and pulverized to a size of 150 mesh, extracted three times for 3 hours at 70 ° C, and filtered. After that, it is concentrated with a rotary evaporator and lyophilized for 72 hours to make a powder with a size of 300 mesh.
둥근빗살현호색(Fumaria officinalis)은 쌍떡잎식물 양귀비목 양귀비과의 한해살이풀로, 피부 보습 및 피부 장벽 개선에 효능이 있다. Round comb corydalis (Fumaria officinalis) is an annual plant of the dicotyledonous poppy plant Papaveraceae, and is effective in moisturizing the skin and improving the skin barrier.
만약, 둥글빗살현호색추출물을 상기의 범위 미만으로 포함할 경우에는 피부보습 및 피부 장벽 개선 효능이 미미하며, 상기의 범위를 초과하여 포함할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If the Corydalis chamomile extract is included in an amount less than the above range, the skin moisturizing and skin barrier improvement effects are insignificant, and if it is included in an amount exceeding the above range, the physical properties may be deteriorated due to the content more than necessary.
석류과피추출물은 석류과피를 세척하고 건조하여 분쇄하고, 용매를 첨가하여 추출한 후, 여과 및 감압 농축하고 동결건조하여 제조한다. Pomegranate peel extract is prepared by washing, drying and pulverizing pomegranate peel, extracting by adding a solvent, filtering, concentrating under reduced pressure, and freeze-drying.
더 상세하게는, 세척하고 수분함량이 5중량% 이하가 되도록 건조하여 100~200mesh의 크기로 분쇄한 석류과피 100중량부에 70% 에탄올 500~1,000중량부를 혼합하고 60~80℃에서 2~4시간 동안 2~5회 반복추출하여 여과한 후, 회전증발농축기로 농축하고 동결건조하여 제조한다. More specifically, 500 to 1,000 parts by weight of 70% ethanol was mixed with 100 parts by weight of pomegranate peel, which was washed, dried to a moisture content of 5% by weight or less, and pulverized to a size of 100 to 200 mesh. After repeated extraction and filtration 2 to 5 times over time, it is prepared by concentrating with a rotary evaporator and freeze-drying.
여기서, 상기 추출온도 및 추출시간을 벗어나게 되면 추출효율이 떨어지거나 성분의 변화가 생길 수 있다. Here, if the extraction temperature and extraction time are out of range, the extraction efficiency may decrease or the components may change.
바람직하게는, 세척하고 수분함량이 5중량% 이하가 되도록 건조하여 150mesh의 크기로 분쇄한 석류과피 100중량부에 70% 에탄올 700중량부를 혼합하고 70℃에서 3시간 동안 3회 반복추출하여 여과한 후, 회전증발농축기로 농축하고 72시간 동결건조하여 300mesh 크기의 분말화한다.Preferably, 700 parts by weight of 70% ethanol is mixed with 100 parts by weight of pomegranate peel, which is washed, dried to a water content of 5% by weight or less, and pulverized to a size of 150 mesh, extracted three times for 3 hours at 70 ° C, and filtered. Then, it is concentrated with a rotary evaporator and lyophilized for 72 hours to make a powder with a size of 300 mesh.
석류과피는 피부수렴 및 미용효과를 가짐과 동시에, 피부유해균인 황색 포도상구균(Staphylococcus aureus), 슈도모나스 에피더미스(Pseudomonas epidermis), 여드름 원인균인 프로피오니 박테리움 아크네균(Propionibacterium acnes), 대장균(E. coli) 등에 항균작용이 우수하여 피부트러블을 방지할 수 있으며, 약리작용으로 살충, 이질균 등의 억제 및 인플루엔자균과 피부진균 억제 효과가 있다.Pomegranate peel has skin astringent and beauty effects, and at the same time, it is effective against skin harmful bacteria such as Staphylococcus aureus, Pseudomonas epidermis, acne-causing bacteria, Propionibacterium acnes, and Escherichia coli (E. coli), etc., it can prevent skin troubles, and it has pharmacological action to inhibit insecticide, dysentery, etc., and to inhibit influenza bacillus and skin fungus.
만약, 석류과피추출물을 상기의 범위 미만으로 포함할 경우에는 피부보습 및 피부수렴 및 항균효능이 미미하며, 상기의 범위를 초과하여 포함할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If the pomegranate peel extract is contained in an amount less than the above range, the skin moisturizing and skin astringent and antibacterial effects are insignificant, and if it is contained in an amount exceeding the above range, the physical properties may be deteriorated due to the content more than necessary.
컴프리잎추출물은 컴프리잎을 세척하고 건조하여 분쇄하고, 용매를 첨가하여 추출한 후, 여과 및 감압 농축하고 동결건조하여 제조한다. Comfrey leaf extract is prepared by washing, drying and pulverizing comfrey leaves, extracting by adding a solvent, filtering, concentrating under reduced pressure, and freeze-drying.
더 상세하게는, 세척하고 수분함량이 5중량% 이하가 되도록 건조하여 100~200mesh의 크기로 분쇄한 컴프리잎 100중량부에 70% 에탄올 500~1,000중량부를 혼합하고 60~80℃에서 2~4시간 동안 2~5회 반복추출하여 여과한 후, 회전증발농축기로 농축하고 동결건조하여 제조한다. More specifically, 500 to 1,000 parts by weight of 70% ethanol was mixed with 100 parts by weight of comfrey leaves washed, dried to a moisture content of 5% by weight or less, and pulverized to a size of 100 to 200 mesh, followed by 2 to 4 parts by weight at 60 to 80 ° C. After repeated extraction and filtration 2 to 5 times over time, it is prepared by concentrating with a rotary evaporator and freeze-drying.
여기서, 상기 추출온도 및 추출시간을 벗어나게 되면 추출효율이 떨어지거나 성분의 변화가 생길 수 있다. Here, if the extraction temperature and extraction time are out of range, the extraction efficiency may decrease or the components may change.
바람직하게는, 세척하고 수분함량이 5중량% 이하가 되도록 건조하여 150mesh의 크기로 분쇄한 컴프리잎 100중량부에 70% 에탄올 700중량부를 혼합하고 70℃에서 3시간 동안 3회 반복추출하여 여과한 후, 회전증발농축기로 농축하고 72시간 동결건조하여 300mesh 크기의 분말화한다.Preferably, 700 parts by weight of 70% ethanol was mixed with 100 parts by weight of comfrey leaves washed, dried to a moisture content of 5% by weight or less, and pulverized to a size of 150 mesh, extracted three times for 3 hours at 70 ° C, and filtered. Then, it is concentrated with a rotary evaporator and lyophilized for 72 hours to make a powder with a size of 300 mesh.
컴프리는 각종 비타민 성분들과 함께 알란토인 및 게르마늄 등 일반 식물에 없는 성분들을 함유하고 있고, 특히 알란토인은 새로운 세포의 성장을 촉진하여 피부 가려움, 피부자극 완화에 도움을 주며, 진정, 항알러지, 항균, 항산화 및 살균작용에 효능이 있다. Comfrey contains ingredients that are not found in general plants, such as allantoin and germanium, along with various vitamin ingredients. In particular, allantoin promotes the growth of new cells to help relieve skin itchiness and skin irritation, soothe, anti-allergic, antibacterial, It is effective in antioxidant and bactericidal action.
만약, 컴프리잎추출물을 상기의 범위 미만으로 포함할 경우에는 피부 가려움, 피부자극 완화, 진정, 항알러지, 항균, 항산화 및 살균작용 효능이 미미하며, 상기의 범위를 초과하여 포함할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If comfrey leaf extract is contained in an amount less than the above range, the efficacy of skin itching, skin irritation relief, soothing, anti-allergy, antibacterial, antioxidant and bactericidal action is insignificant, and if it is contained in excess of the above range, it is more than necessary. Due to the content, physical properties may rather deteriorate.
판테놀(panthenol)은 실온에서 점성이 있는 투명한 액체로서, 판토텐산의 알코올 유사체로 B5의 프로비타민이고, 의약품 및 화장품에서 보습제, 습윤제 및 연화제로 사용되고 있으며, 피부의 가려움증과 염증완화, 수분공급, 탄력개선 및 상피 상처의 치유속도를 가속시키는 역할을 한다. Panthenol is a viscous transparent liquid at room temperature. It is an alcohol analog of pantothenic acid and is a provitamin of B5. It is used as a moisturizer, humectant and softener in pharmaceuticals and cosmetics. And it serves to accelerate the healing rate of epithelial wounds.
만약, 판테놀을 상기의 범위 미만으로 포함할 경우에는 피부의 가려움증과 염증완화, 수분공급, 탄력개선 및 상피 상처의 치유 속도를 가속시키는 역할이 미미하, 상기의 범위를 초과하여 포함할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If panthenol is included below the above range, the role of relieving itching and inflammation of the skin, supplying moisture, improving elasticity, and accelerating the healing rate of epithelial wounds is insignificant. Due to the above content, the physical properties may rather deteriorate.
1,2-헥산다이올(1,2-Hexanediol)은 소수성, 친수성 성질을 모두 가지고 있어 계면활성제의 구조를 띄고 있고, 피부의 수분증발을 차단해주게 되어 보습력을 부여하여 피부 컨디셔닝 효과가 있으며, 방부제, 보존제 역할을 할 뿐만 아니라, 물과 잘 섞이고 오일성분에 유화성이 있어 물에 잘 섞이지 않는 유효성분을 잘 섞일 수 있도록 도와주어 안정성을 높여주는 역할을 한다. 1,2-hexanediol (1,2-Hexanediol) has both hydrophobic and hydrophilic properties and has the structure of a surfactant. , Not only does it act as a preservative, but it also mixes well with water and has emulsifying properties in oil components, so it helps active ingredients that do not mix well with water to mix well, thereby enhancing stability.
만약, 1,2-헥산다이올을 상기의 범위 미만으로 포함할 경우에는 보습제, 방부제 및 보존제 역할 이외에도 전체적인 안정성을 높이기 어려우며, 상기의 범위를 초과하여 포함할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If 1,2-hexanediol is included below the above range, it is difficult to increase the overall stability in addition to the role of a moisturizer, preservative and preservative. may be lowered
1,3-부틸렌글리콜(1,3-Butylene glycol)은 무취의 감미를 가진 점성액체로서, 습윤성, 용해성 및 항균성이 있고 피부에 대한 자극성, 독성이 거의 없으며, 공기로부터 수분을 흡수하는 수분결합능력과 수분을 끌어당기는 기능이 있어 피부를 촉촉하게 유지시켜 주어 보습력이 높고, 더불어 글라이콜 성분으로 보존기능도 높아서 방부제 기능을 보완하는 역할을 한다. 1,3-Butylene glycol (1,3-Butylene glycol) is a viscous liquid with an odorless sweetness. It has wettability, solubility and antibacterial properties. It has little irritation or toxicity to the skin. It absorbs moisture from the air. It has the ability to attract moisture and keeps the skin moist, so it has high moisturizing power. In addition, the glycol component has a high preservative function, so it supplements the preservative function.
만약, 1,3-부틸렌글리콜을 상기의 범위 미만으로 포함할 경우에는 보습력, 방부제 역할을 충분히 하기 어려우며, 상기의 범위를 초과하여 포함할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If 1,3-butylene glycol is included in an amount less than the above range, it is difficult to sufficiently act as a moisturizing agent and preservative, and if it is included in an amount exceeding the above range, the physical properties may be deteriorated due to the content more than necessary. .
에틸헥실클리세린(Ethylhexylglycerin)은 글리세릴에테르 성분으로 알코올의 유기화합물 성분으로서, 건조 및 손상된 피부 보습 개선하고, 악취의 원인이 되는 혐기성 박테리아의 성장을 억제하는 탈취효능이 있으며, 항균력을 높이는 역할을 한다. Ethylhexylglycerin is an organic compound of alcohol as a glyceryl ether component. It improves dry and damaged skin moisturization, has a deodorizing effect that inhibits the growth of anaerobic bacteria that cause odor, and plays a role in increasing antibacterial power. do.
만약, 에틸헥실클리세린을 상기의 범위 미만으로 포함할 경우에는 보습력, 탈취효능, 항균력을 충분히 높이기 어려우며, 상기의 범위를 초과하여 포함할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If ethylhexylglycerin is included below the above range, it is difficult to sufficiently increase the moisturizing power, deodorizing effect, and antibacterial power, and when it is included in excess of the above range, the physical properties may deteriorate due to the content more than necessary.
알란토인(allantoin)은 컴프리, 사탕무 등 다양한 식물에서 추출 가능한 자연 유래 성분인 활성보습성분으로서, 상처난 피부를 치유하는 재생효과가 높고, 피부를 진정시켜주는 안전한 항-자극제 성분이며, 경미한 상처나 치료에 효과적이고, 항알러지 및 항염기능을 갖고 있다. Allantoin is an active moisturizing ingredient that is a naturally derived ingredient that can be extracted from various plants such as comfrey and sugar beet. It has anti-allergic and anti-inflammatory properties.
만약, 알란토인을 상기의 범위 미만으로 포함할 경우에는 재생효과, 진정효과, 항알러지 및 항염기능을 충분히 높이기 어려우며, 상기의 범위를 초과하여 포함할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If allantoin is included in an amount less than the above range, it is difficult to sufficiently enhance the regenerative effect, soothing effect, anti-allergy and anti-inflammatory function, and if it is included in an amount exceeding the above range, the physical properties may deteriorate due to the content more than necessary. there is.
디소듐이디티에이(disodium EDTA)은 금속이온봉쇄제로서, 물에 잘 녹고 금속이온들이나 제품들이 시간이 지남에 따라 공기가 혼입되어 부식 또는 산패가 되는 현상을 막아 산화물질과 유해물질이 생성되지 못하도록 하는 역할을 하며, 조성물들이 피부에 스며들어 잘 흡수될 수 있도록 도와주는 촉매제 및 변색방지의 역할을 한다. Disodium EDTA is a sequestering agent for metal ions. It dissolves well in water and prevents metal ions or products from being corroded or rancid due to mixing of air over time, so that oxides and harmful substances are not generated. It acts as a catalyst and prevents discoloration to help the composition permeate into the skin and be well absorbed.
만약, 디소듐이디티에이를 상기의 범위 미만으로 포함할 경우에는 촉매제 및 변색방지 역할을 충분히 수행하기 어려우며, 상기의 범위를 초과하여 포함할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If disodium EDTA is included below the above range, it is difficult to sufficiently perform the role of catalyst and discoloration prevention, and when it is included beyond the above range, physical properties may deteriorate due to the content more than necessary. .
암모늄아크릴로일디메칠타우레이트(Ammonium Acryloyldimethyltaurate)는 UV에 안정하고 넓은 pH 범위에서 기능을 하며, 물에 용해되고 우수한 분산 능력을 지닌 고분자 겔화제 성분으로 점도를 조절하고, 피부 피막 형성 역할을 한다. Ammonium Acryloyldimethyltaurate (Ammonium Acryloyldimethyltaurate) is UV-stable, functions in a wide pH range, is soluble in water, and has excellent dispersibility.
만약, 암모늄아크릴로일디메칠타우레이트를 상기의 범위 미만으로 포함할 경우에는 분산능력을 충분히 발휘하지 못하여 원하는 점도로 조절하기 어려우며, 상기의 범위를 초과하여 포함할 경우에는 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If ammonium acryloyldimethyltaurate is included in an amount less than the above range, the dispersing ability is not sufficiently exhibited, making it difficult to adjust the viscosity to a desired level. this may deteriorate.
상기와 같은 본 발명의 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물의 점도는 300~7,000cPs이고, pH는 4~7로 형성될 수 있다. The viscosity of the adhesive transparent wound coating composition containing the corydalis extract, pomegranate peel extract, and comfrey leaf extract of the present invention as described above may be formed at a viscosity of 300 to 7,000 cPs and a pH of 4 to 7.
이를 통해, 피부 및 두피 등에 도포하면 빠르게 건조되어 피막을 형성함으로써 손상부위를 보호하고 습윤환경을 유지하고, 건조된 피부로 인한 가려움증 및 염증, 흉터발생을 완화해 줄 수 있게 된다. Through this, when applied to the skin and scalp, etc., it dries quickly to form a film to protect the damaged area, maintain a moist environment, and relieve itching, inflammation, and scarring caused by dry skin.
만약, 상기와 같은 본 발명의 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물의 점도가 300cPs 미만일 경우에는 피부 및 두피 등에 도포가 용이하지 않을 뿐만 아니라 필요 부위에 고르게 도포되지 않을 수 있으며, 7,000cPs를 초과할 경우에는 피부, 두피 등에 도포하면 피막형성이 용이하지 않는 문제가 발생한다. If the viscosity of the adhesive transparent wound covering composition containing the corydalis extract, pomegranate peel extract, and comfrey leaf extract of the present invention as described above is less than 300 cPs, it is not easy to apply to the skin and scalp, and evenly applied to the necessary area. It may not be applied, and if it exceeds 7,000 cPs, a problem in that it is not easy to form a film occurs when applied to the skin or scalp.
본 발명에서는 상기 정제수에 갈근추출물, 감초추출물, 천궁추출물, 지실추출물, 작약추출물 및 에필로비움플레이스케리추출물을 동량으로 혼합하여 더 포함할 수 있다.In the present invention, the purified water may be further included by mixing equal amounts of algae root extract, licorice extract, cnidaria extract, forsythia extract, peony extract, and epilobium place skerry extract.
더 상세하게는, 상기 정제수 100중량부에 대하여 갈근추출물, 감초추출물, 천궁추출물, 지실추출물, 작약추출물 및 에필로비움플레이스케리추출물을 동량으로 혼합한 혼합물 3~7중량부를 더 포함하는 것이다. More specifically, it further comprises 3 to 7 parts by weight of a mixture obtained by mixing equal amounts of horseradish root extract, licorice extract, cnidium extract, palm tree extract, peony extract and epilobium place keri extract with respect to 100 parts by weight of the purified water.
이를 통해, 본 발명의 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물에 보습 및 영양과 컨디셔닝을 더 부여하여 피부 및 두피의 손상부위를 보호하고 습윤환경을 유지하고, 건조된 피부로 인한 가려움증 및 염증, 흉터발생의 완화를 증진시켜 줄 수 있게 된다. Through this, moisturizing, nutrition, and conditioning are further imparted to the adhesive transparent wound covering composition containing the Corydalis extract, pomegranate peel extract, and comfrey leaf extract of the present invention to protect damaged areas of the skin and scalp, maintain a moist environment, , itching and inflammation due to dry skin, it is possible to promote the alleviation of scarring.
갈근추출물, 감초추출물, 천궁추출물, 지실추출물 및 작약추출물은 각각 세척하고 건조하여 분쇄하고, 용매를 첨가하여 추출한 후, 여과 및 감압 농축하고 동결건조하여 제조한다. The algae root extract, licorice extract, cnidium extract, eggplant extract, and peony extract are prepared by washing, drying, pulverizing, extracting by adding a solvent, filtering, concentrating under reduced pressure, and freeze-drying.
더 상세하게는, 세척하고 수분함량이 5중량% 이하가 되도록 건조하여 100~200mesh의 크기로 분쇄한 각각의 갈근, 감초, 천궁, 지실 및 작약 100중량부에 70% 에탄올 500~1,000중량부를 혼합하고 60~80℃에서 2~4시간 동안 2~5회 반복추출하여 여과한 후, 회전증발농축기로 농축하고 동결건조하여 제조한다. More specifically, 500 to 1,000 parts by weight of 70% ethanol is mixed with 100 parts by weight of each root, licorice, cnidium, branch, and peony that are washed, dried to a moisture content of 5% by weight or less, and pulverized to a size of 100 to 200 mesh. After repeated extraction and filtration 2 to 5 times for 2 to 4 hours at 60 to 80 ° C., concentrated with a rotary evaporator and freeze-dried.
바람직하게는, 세척하고 수분함량이 5중량% 이하가 되도록 건조하여 150mesh의 크기로 분쇄한 각각의 갈근, 감초, 천궁, 지실 및 작약 100중량부에 70% 에탄올 700중량부를 혼합하고 70℃에서 3시간 동안 3회 반복추출하여 여과한 후, 회전증발농축기로 농축하고 72시간 동결건조하여 300mesh 크기의 분말화한다.Preferably, 700 parts by weight of 70% ethanol was mixed with 100 parts by weight of each root, licorice, cnidium, branch, and peony that were washed and dried to a moisture content of 5% by weight or less and pulverized to a size of 150 mesh, followed by mixing 3 parts by weight of 70% ethanol at 70 ° C. After repeated extraction and filtration three times over time, the mixture was concentrated with a rotary evaporator and lyophilized for 72 hours to make a powder with a size of 300 mesh.
갈근은 계면활성제와 방부제로 인한 피부자극에 민감성 피부를 위해 자극완화 및 피부진정 효과가 있고, 주성분인 플라보노이드가 피부를 관리하며, 피부노화의 원인인 활성산소를 억제하여 피부의 산화를 예방하고, 영양과 컨디셔닝을 부여하여 활력있고 생기있게 도와주는 역할을 한다. For skin that is sensitive to skin irritation caused by surfactants and preservatives, galgeun relieves irritation and soothes the skin, and its main ingredient, flavonoids, manages the skin, suppresses active oxygen, which is the cause of skin aging, and prevents skin oxidation. It provides nutrition and conditioning to help vitality and vitality.
감초는 다량의 폴리페놀 성분인 이소리퀴리티제닌(isoliquiritigenin)의 함유를 통해 항산화, 미백 등의 효능이 있다. Licorice has antioxidant and whitening effects through the containment of isoliquiritigenin, a large amount of polyphenol component.
천궁은 특유의 향이 있고 항산화 작용으로 활성산소를 억제하여 피부를 보호하며, 피부의 수분증발을 차단해주게 되어 보습력을 부여하여 피부 컨디셔닝 효능이 있다.Cnidium has a unique fragrance, protects the skin by suppressing active oxygen through antioxidant action, and blocks moisture evaporation of the skin, thereby providing moisturizing power and providing skin conditioning effect.
지실은 특유의 향이 있고 항산화 작용으로 활성산소를 억제하여 피부를 보호하며, 모공수축 및 피부의 수분증발을 차단해주게 되어 보습력을 부여하여 피부 컨디셔닝 효능이 있다.Jisil has a unique fragrance, protects the skin by suppressing active oxygen through antioxidant action, and blocks pore contraction and moisture evaporation of the skin, thereby providing moisturizing power and having skin conditioning effects.
작약은 피오니플로린 성분을 통해 진정, 항염 및 항균작용을 하고, 콜라겐 섬유의 활성을 촉진하여 노화방지 효능을 가지며, 항산화작용을 통해 활성산소를 억제하여 피부를 보호하는 효능이 있다.Peony has soothing, anti-inflammatory and antibacterial action through peonyflorin component, has anti-aging effect by promoting activation of collagen fiber, and has effect of protecting skin by suppressing active oxygen through antioxidant action.
에필로비움플레이스케리추출물은 에필로비움플레이스케리(Epilobium fleischeri) 의 전초에서 추출한 것으로서, 컨디셔닝제, 수렴제, 피지를 조절하여 모공수축에 도움을 준다. Epilobium place cheri extract is extracted from the outpost of Epilobium fleischeri, and helps to shrink pores by controlling conditioning agents, astringents, and sebum.
만약, 갈근추출물, 감초추출물, 천궁추출물, 지실추출물, 작약추출물 및 에필로비움플레이스케리추출물을 동량으로 혼합한 혼합물을 상기의 범위 미만으로 포함할 경우에는 각각의 효과가 미미하며, 상기의 범위를 초과하여 포함할 경우에는 각각의 특유의 향이 강하게 되어 거부감을 줄 수 있으며, 필요 이상의 함유량으로 인하여 오히려 물성이 저하될 수 있다. If a mixture containing equal amounts of horseradish root extract, licorice extract, cnidium extract, eggplant extract, peony extract, and epilobium placellary extract is included in an amount less than the above range, each effect is insignificant, and the above range If it is included in excess, each unique scent can be strengthened to give a sense of rejection, and due to the content more than necessary, physical properties may rather deteriorate.
본 발명에 따르면, 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물 등의 천연추출물을 포함한 점착성 투명 창상 피복재 조성물을 통해 건조한 피부 및 두피 등 피부 장벽이 손상된 부위를 보호하고, 피부 장벽이 파괴된 피부 및 두피에 물리적인 막을 형성하며, 피부 환경에 수분을 유지시켜 건조된 피부로 인한 가려움 내지 흉터 발생을 완화해 줄 수 있는 효과가 있다.According to the present invention, through an adhesive transparent wound covering composition containing natural extracts such as chamomile extract, pomegranate peel extract, and comfrey leaf extract, it protects areas where the skin barrier is damaged, such as dry skin and scalp, and the skin barrier is destroyed. And it forms a physical film on the scalp, and has an effect of relieving itching or scarring due to dry skin by maintaining moisture in the skin environment.
이하에서 실시예를 통하여 본 발명을 더욱 구체적으로 설명한다. 그러나 하기의 실시예는 본 발명을 구체적으로 예시하기 위한 것일 뿐, 본 발명의 권리범위를 제한하는 것이 아님은 통상의 기술자에게 있어서 명백한 사실이다. 즉, 본 발명의 단순한 변형 내지 변경은 통상의 기술자에 의하여 쉽게 실시될 수 있으며, 이러한 변형이나 변경은 모두 본 발명의 영역에 포함되는 것으로 볼 수 있다. Hereinafter, the present invention will be described in more detail through examples. However, it is clear to those skilled in the art that the following examples are only intended to specifically illustrate the present invention and do not limit the scope of the present invention. That is, simple modifications or changes of the present invention can be easily performed by a person skilled in the art, and all such modifications or changes can be considered to be included in the scope of the present invention.
하기 표 1에 나타난 성분으로 점착성 투명 창상 피복재를 제조하였다. An adhesive transparent wound covering material was prepared with the components shown in Table 1 below.
상기 표 1의 조성을 바탕으로, 60~70℃에서 각각의 성분을 고르게 혼합하고 교반하여 용해시켰다. 이후, 상온에서 냉각시켜 점착성 투명 창상 피복재를 제조하였다.Based on the composition of Table 1, each component was evenly mixed and stirred to dissolve at 60 to 70 ° C. Then, it was cooled at room temperature to prepare an adhesive transparent wound covering material.
실험 : 임상실험 Experiment: Clinical trial
(1) 두피의 모낭사이홍반 및 모낭홍반농포 측정(1) Measurement of interfollicular erythema and follicular erythema pustules on the scalp
본 발명에 따른 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물을 이용하여 제조된 점착성 투명 창상 피복재(실시예 1 및 2)와 비교예 1 내지 8을 통해 두피 개선효과를 검증하기 위하여, AI-Scalp grader를 이용하여 두피의 모낭사이홍반 및 모낭홍반농포를 정량적인 수치로 측정하였다. Scalp improvement through the adhesive transparent wound covering material (Examples 1 and 2) and Comparative Examples 1 to 8 prepared using the adhesive transparent wound covering composition containing the corydalis corydalis extract, pomegranate peel extract and comfrey leaf extract according to the present invention In order to verify the effect, AI-Scalp grader was used to measure erythema between hair follicles and erythema follicular pustules on the scalp quantitatively.
AI-Scalp grader는 0~3(0 정상, 1 경증, 2 중등, 3 중증)점으로 1점 이상 즉, 경증 이상의 총 8명을 대상으로 도포 전과 도포 4주 후로 나누어 실험하였으며, 그 결과는 표 2 및 표 3에 나타내었다. The AI-Scalp grader was tested before application and 4 weeks after application on a total of 8 people with more than 1 point on a scale of 0 to 3 (0 normal, 1 mild, 2 moderate, 3 severe), that is, more than mild symptoms, and the results are shown in the table 2 and Table 3.
표 2 및 표 3에 나타난 바와 같이, 본 발명에 따른 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물을 이용하여 제조된 점착성 투명 창상 피복재(실시예 1 및 2)는 비교예 1 내지 7보다 모낭사이홍반 및 모낭홍반농포 개선효과가 더 높은 것을 알 수 있다. 이는, 실시예 1 및 2에서 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 모두 포함하여 최적의 혼합비율을 통해 제조되었기에 장벽이 파괴된 두피에 물리적인 막을 형성하고, 피부 환경에 수분을 유지시켜 호전되는 양상을 보인 결과로 풀이된다. As shown in Tables 2 and 3, the adhesive transparent wound coating material prepared using the adhesive transparent wound coating composition containing the corydalis extract, pomegranate peel extract and comfrey leaf extract according to the present invention (Examples 1 and 2) It can be seen that the improvement effect of interfollicular erythema and follicular erythema pustules is higher than that of Comparative Examples 1 to 7. This is because it was prepared through the optimal mixing ratio including all of the Corydalis extract, pomegranate peel extract, and comfrey leaf extract in Examples 1 and 2, so it forms a physical film on the scalp where the barrier is destroyed, and maintains moisture in the skin environment It is interpreted as a result of showing an improvement by doing so.
또한, 비교예 8은 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 모두 포함하되, 본 발명의 혼합비율을 초과하여 제조된 것으로서, 그 효과에 있어서는 본 발명의 혼합비율로 제조된 실시예 1과 유사한 것을 알 수 있다. 따라서, 조성물의 점도, 경제성을 고려하여 본 발명의 혼합비율을 통해 제조하는 것이 적절하다고 판단된다. In addition, Comparative Example 8 was prepared by exceeding the mixing ratio of the present invention, but including all of the corydalis extract, pomegranate peel extract, and comfrey leaf extract, and in terms of the effect, Example 1 prepared with the mixing ratio of the present invention can be found similar to Therefore, it is determined that it is appropriate to prepare through the mixing ratio of the present invention in consideration of the viscosity and economic feasibility of the composition.
(2) 두피상태 관찰 (2) Observation of scalp condition
본 발명에 따른 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물을 이용하여 제조된 점착성 투명 창상 피복재(실시예 1 및 2)를 최연소 만 40세, 최고령자 만 60세로 10명(남자 5명, 여자 5명)으로 하여금 도포 전과 도포 4주 후로 나누어 두피의 앞중앙, 정수리, 좌측부, 우측부 및 후두부의 두피상태를 관찰하였다. 그 결과는 도 1 내지 도 10에 나타내었다. The adhesive transparent wound covering material (Examples 1 and 2) prepared using the adhesive transparent wound coating composition containing the corydalis extract, pomegranate peel extract and comfrey leaf extract according to the present invention was applied to the youngest 40 years old and the oldest 60 years old 10 people (5 males, 5 females) were divided into before application and 4 weeks after application, and the condition of the scalp in the front center, crown, left side, right side, and occipital region of the scalp was observed. The results are shown in Figures 1 to 10.
도 1 내지 도 5는 본 발명에 따른 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물을 이용하여 제조된 점착성 투명 창상 피복재(실시예 1)의 두피 도포 전 후의 사진이고, 도 6 내지 도 10은 본 발명에 따른 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물을 이용하여 제조된 점착성 투명 창상 피복재(실시예 2)의 두피 도포 전 후의 사진이다. 1 to 5 are photos before and after scalp application of the transparent adhesive wound coating material (Example 1) prepared using the adhesive transparent wound coating composition containing the corydalis corydalis extract, pomegranate peel extract and comfrey leaf extract according to the present invention. 6 to 10 are before scalp application of the adhesive transparent wound coating material (Example 2) prepared using the adhesive transparent wound coating composition containing the corydalis chamomile extract, pomegranate peel extract and comfrey leaf extract according to the present invention. This is the after photo.
도 1 내지 10에 나타난 바와 같이, 본 발명에 따른 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물을 이용하여 제조된 점착성 투명 창상 피복재(실시예 1 및 2)의 두피 도포 4주 후, 도포된 10명 모두 피부 장벽이 파괴된 두피에 물리적인 막을 형성하고, 피부 환경에 수분을 유지시켜 호전되는 양상을 보인 것을 알 수 있다. As shown in FIGS. 1 to 10, the adhesive transparent wound coating material (Examples 1 and 2) prepared using the adhesive transparent wound coating composition containing the corydalis extract, pomegranate peel extract and comfrey leaf extract according to the present invention It can be seen that after 4 weeks of scalp application, all 10 applied persons showed improvement by forming a physical film on the scalp where the skin barrier was destroyed and maintaining moisture in the skin environment.
Claims (4)
에탄올(ethanol) 10~20중량부, 베타글루칸(β-glucan) 7~15중량부, 둥글빗살현호색추출물 2~3중량부, 석류과피추출물 3~5중량부, 컴프리잎추출물 1~2중량부, 판테놀(panthenol) 7~15중량부, 1,2-헥산다이올(1,2-Hexanediol) 2~5중량부, 1,3-부틸렌글리콜(1,3-Butylene glycol) 1~3중량부, 에틸헥실클리세린(Ethylhexylglycerin) 0.05~0.1중량부, 알란토인(allantoin) 0.03~0.1중량부, 디소듐이디티에이(disodium EDTA) 0.01~0.05중량부 및 암모늄아크릴로일디메칠타우레이트(Ammonium Acryloyldimethyltaurate) 1~3중량부를 포함하는 것을 특징으로 하는 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물.
Regarding 100 parts by weight of purified water,
10-20 parts by weight of ethanol, 7-15 parts by weight of beta-glucan, 2-3 parts by weight of Corydalis extract, 3-5 parts by weight of pomegranate peel extract, 1-2 parts by weight of comfrey leaf extract , 7-15 parts by weight of panthenol, 2-5 parts by weight of 1,2-Hexanediol, 1-3 parts by weight of 1,3-butylene glycol ethylhexylglycerin 0.05-0.1 parts by weight, allantoin 0.03-0.1 parts by weight, disodium EDTA 0.01-0.05 parts by weight and ammonium acryloyldimethyltaurate ) An adhesive transparent wound coating composition containing 1 to 3 parts by weight of Corydalis extract, pomegranate peel extract and comfrey leaf extract.
상기 정제수 100중량부에 대하여,
갈근추출물, 감초추출물, 천궁추출물, 지실추출물, 작약추출물 및 에필로비움플레이스케리추출물을 동량으로 혼합한 혼합물 3~7중량부를 더 포함하는 것을 특징으로 하는 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물.
According to claim 1,
With respect to 100 parts by weight of the purified water,
Corydalis extract, pomegranate rind extract and comfrey leaf, characterized in that it further comprises 3 to 7 parts by weight of a mixture obtained by mixing equal amounts of algae root extract, licorice extract, cnidium extract, eggplant extract, peony extract and epilobium placerary extract in equal amounts An adhesive transparent wound covering composition containing an extract.
상기 점착성 투명 창상 피복재 조성물은,
점도 300~7,000cPs, pH 4~7로 형성되는 것을 특징으로 하는 둥글빗살현호색추출물, 석류과피추출물 및 컴프리잎추출물을 함유하는 점착성 투명 창상 피복재 조성물.According to claim 1,
The adhesive transparent wound covering composition,
An adhesive transparent wound covering composition containing a coriander extract, a pomegranate peel extract, and a comfrey leaf extract, characterized in that it is formed at a viscosity of 300 to 7,000 cPs and a pH of 4 to 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220125528A KR102510213B1 (en) | 2022-09-30 | 2022-09-30 | The adhesive transparent wound covering material composition containing fumaria officinalis, pomegranate shell extract and comfrey leaf extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020220125528A KR102510213B1 (en) | 2022-09-30 | 2022-09-30 | The adhesive transparent wound covering material composition containing fumaria officinalis, pomegranate shell extract and comfrey leaf extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102510213B1 true KR102510213B1 (en) | 2023-03-15 |
Family
ID=85512214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020220125528A KR102510213B1 (en) | 2022-09-30 | 2022-09-30 | The adhesive transparent wound covering material composition containing fumaria officinalis, pomegranate shell extract and comfrey leaf extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102510213B1 (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001010945A (en) * | 1999-07-02 | 2001-01-16 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing moisture retaining plant extract |
KR20100107826A (en) * | 2009-03-26 | 2010-10-06 | (주)지앤지 | Cosmetic compositions improving atopic dermatitis by complex function of damaged skin barrier repairing by lipid exchange and desensitizing, anti-inflammation and its manufacturing method thereof |
KR20160007534A (en) * | 2013-05-16 | 2016-01-20 | 디에스엠 아이피 어셋츠 비.브이. | Cosmetic composition comprising a sebum control agent, a skin exfoliation agent and/or a collagen enhancing agent, the composition also comprising porous cross-linked polymethylmethacrylate bead particles |
KR20210060150A (en) | 2019-11-18 | 2021-05-26 | (주)트리젠 | Wound dressing material composition and wound dressing material containing the same |
US20210212964A1 (en) * | 2018-06-08 | 2021-07-15 | Vivier Canada Inc. | Sterile topical saline putrescine formulation and uses thereof |
JP6988016B1 (en) * | 2021-04-22 | 2022-01-05 | 佐藤製薬株式会社 | Granzyme B inhibitor |
-
2022
- 2022-09-30 KR KR1020220125528A patent/KR102510213B1/en active IP Right Grant
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001010945A (en) * | 1999-07-02 | 2001-01-16 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing moisture retaining plant extract |
KR20100107826A (en) * | 2009-03-26 | 2010-10-06 | (주)지앤지 | Cosmetic compositions improving atopic dermatitis by complex function of damaged skin barrier repairing by lipid exchange and desensitizing, anti-inflammation and its manufacturing method thereof |
KR20160007534A (en) * | 2013-05-16 | 2016-01-20 | 디에스엠 아이피 어셋츠 비.브이. | Cosmetic composition comprising a sebum control agent, a skin exfoliation agent and/or a collagen enhancing agent, the composition also comprising porous cross-linked polymethylmethacrylate bead particles |
US20210212964A1 (en) * | 2018-06-08 | 2021-07-15 | Vivier Canada Inc. | Sterile topical saline putrescine formulation and uses thereof |
KR20210060150A (en) | 2019-11-18 | 2021-05-26 | (주)트리젠 | Wound dressing material composition and wound dressing material containing the same |
JP6988016B1 (en) * | 2021-04-22 | 2022-01-05 | 佐藤製薬株式会社 | Granzyme B inhibitor |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2525245T3 (en) | A product for topical administration | |
EP3153185B1 (en) | Composition containing glucosylglycerol for promoting the regeneration of injured body tissue | |
KR101868263B1 (en) | moisturizing cosmetic composition | |
CN108567638B (en) | Moisturizing dressing with epidermis repairing function | |
Abdulla et al. | Wound healing activities of Rafflesia hasseltii extract in rats | |
CN108186679B (en) | Acne removing composition | |
KR102520221B1 (en) | Cosmetic Composition For Improving Skin Whitening and Anti-wrinkling Comprising Extract Of Cannabis | |
EP2632475B1 (en) | Compositions for the treatment of peripheral ulcers of various origins | |
KR102099269B1 (en) | Two-part skin care formulations | |
CN108653129B (en) | Skin dressing containing natural plant anti-allergy composition | |
CN111568826A (en) | Oral care composition capable of resisting inflammation, relieving pain and preventing ulcer, oral care toothpaste and preparation method of oral care toothpaste | |
CN111228207B (en) | Dampness-rash-eliminating hip-protecting cream and preparation method thereof | |
US7262224B2 (en) | Cosmetic rejuvenating and healing product, method of its manufacture and uses thereof | |
GB2543091A (en) | A topical herbal healing formulation | |
KR102510213B1 (en) | The adhesive transparent wound covering material composition containing fumaria officinalis, pomegranate shell extract and comfrey leaf extract | |
KR101418366B1 (en) | Composition containing bee venom and propolis for preventing or treating acne | |
ES2909243T3 (en) | Salvia haenkei extract as an active agent in re-epithelialization and tissue healing processes | |
EP2238981A1 (en) | Composition comprising mucilaginous polysaccharides derived from aloe barbadensis combined with liposomes, method for obtaining same and use thereof as a sun protector, an anti-acne agent, an epidermal regenerator and a moisturiser | |
CN114848517A (en) | Moisturizing, oil-controlling, anti-inflammatory, bacteriostatic and acne-removing composition, acne-removing cosmetic containing composition and preparation method of acne-removing cosmetic | |
KR102218008B1 (en) | Manufacturing method of hydrogel mask pack by using aloe and hydrogel mask pack by the same | |
US8491941B1 (en) | Rash treatment with scar prevention | |
CN111671696A (en) | Acne removing cream and preparation method thereof | |
KR102605440B1 (en) | Cosmetic composition for spraying or applying to women's Y-zone, which uses Leonurus sibiricus extract as the main ingredient | |
AU2021103390A4 (en) | A Skincare Oil | |
CN111700825B (en) | Oily composition for oral health care, preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |